# Official Journal C 315/2011

| | ISSN 1977-091X
  doi:10.3000/1977091X.C_2011.315.eng |
| --- | --- |
| Official Journal
  of the European Union | C 315 |
| | |
| English edition | Information and Notices | Volume 5428 October 2011 |

ISSN 1977-091X

doi:10.3000/1977091X.C_2011.315.eng

Official Journal

of the European Union

C 315

English edition

Information and Notices

Volume 5428 October 2011

---

| Notice No | Contents | page |
| --- | --- | --- |
| | I   Resolutions, recommendations and opinions |
| | RECOMMENDATIONS |
| | European Commission |
| 2011/C 315/01 | Commission Recommendation of 27 October 2011 on the research Joint Programming Initiative The Microbial Challenge — An Emerging Threat to Human Health | 1 |

Notice No

Contents

page

I   Resolutions, recommendations and opinions

RECOMMENDATIONS

European Commission

2011/C 315/01

Commission Recommendation of 27 October 2011 on the research Joint Programming Initiative The Microbial Challenge — An Emerging Threat to Human Health

1

| | II   Information |
| --- | --- |
| | INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2011/C 315/02 | Non-opposition to a notified concentration (Case COMP/M.6223 — Aegon/Banca Civica/Cajaburgos Vida) (
  1
  ) | 4 |
| 2011/C 315/03 | Authorisation for State aid pursuant to Articles 107 and 108 of the TFEU — Cases where the Commission raises no objections (
  2
  ) | 5 |

II   Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2011/C 315/02

Non-opposition to a notified concentration (Case COMP/M.6223 — Aegon/Banca Civica/Cajaburgos Vida) (
  1
  )

1

4

2011/C 315/03

Authorisation for State aid pursuant to Articles 107 and 108 of the TFEU — Cases where the Commission raises no objections (
  2
  )

2

5

| | IV   Notices |
| --- | --- |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2011/C 315/04 | Euro exchange rates | 8 |
| | NOTICES FROM MEMBER STATES |
| 2011/C 315/05 | Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 1857/2006 on the application of Articles 87 and 88 of the Treaty to State aid to small and medium-sized enterprises active in the production of agricultural products and amending Regulation (EC) No 70/2001 | 9 |

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2011/C 315/04

Euro exchange rates

8

NOTICES FROM MEMBER STATES

2011/C 315/05

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 1857/2006 on the application of Articles 87 and 88 of the Treaty to State aid to small and medium-sized enterprises active in the production of agricultural products and amending Regulation (EC) No 70/2001

9

| | V   Announcements |
| --- | --- |
| | PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY |
| | European Commission |
| 2011/C 315/06 | Prior notification of a concentration (Case COMP/M.6404 — Hochtief Solutions/Ventizz/JV) — Candidate case for simplified procedure (
  1
  ) | 11 |

V   Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

2011/C 315/06

Prior notification of a concentration (Case COMP/M.6404 — Hochtief Solutions/Ventizz/JV) — Candidate case for simplified procedure (
  1
  )

1

11

| | |
| --- | --- |
| | (1)   Text with EEA relevance |
| | (2)   Text with EEA relevance, except for products falling under Annex I to the Treaty |

---

(1)   Text with EEA relevance

1

(2)   Text with EEA relevance, except for products falling under Annex I to the Treaty

2

| EN | |
| --- | --- |

EN

---

I Resolutions, recommendations and opinions

RECOMMENDATIONS

European Commission

| 28.10.2011 | EN | Official Journal of the European Union | C 315/1 |
| --- | --- | --- | --- |

28.10.2011

EN

Official Journal of the European Union

C 315/1

---

COMMISSION RECOMMENDATION

of 27 October 2011

on the research Joint Programming Initiative ‘The Microbial Challenge — An Emerging Threat to Human Health’

2011/C 315/01

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union, and in particular Article 181 and Article 292 thereof,

Whereas:

| (1) | The microbial challenge, due to the increasing resistance to antimicrobial drugs, represents one of the major emerging threats to human health in the 21st century (1). More than 25 000 patients die in the Union each year from infections caused by bacteria that are resistant to multiple antibiotics, so-called multidrug-resistant bacteria (2). Resistance rates to a single antibiotic exceed 40-50 % in some European countries (3), and resistance to multiple antibiotics is a common and growing problem. |
| --- | --- |

(1)

The microbial challenge, due to the increasing resistance to antimicrobial drugs, represents one of the major emerging threats to human health in the 21st century (1). More than 25 000 patients die in the Union each year from infections caused by bacteria that are resistant to multiple antibiotics, so-called multidrug-resistant bacteria (2). Resistance rates to a single antibiotic exceed 40-50 % in some European countries (3), and resistance to multiple antibiotics is a common and growing problem.

| (2) | Infectious diseases caused by resistant bacteria lead to additional healthcare costs and indirect costs, such as sick-leave and lost output due to premature death. The overall direct costs to society in terms of extra healthcare costs and productivity losses total EUR 1,5 billion each year in Europe (4); and the indirect costs to European countries are likely to be several times higher (5). |
| --- | --- |

(2)

Infectious diseases caused by resistant bacteria lead to additional healthcare costs and indirect costs, such as sick-leave and lost output due to premature death. The overall direct costs to society in terms of extra healthcare costs and productivity losses total EUR 1,5 billion each year in Europe (4); and the indirect costs to European countries are likely to be several times higher (5).

| (3) | The problem of drug resistance is a natural and unavoidable consequence of treating infectious diseases with antimicrobial drugs. However, this is exacerbated by indiscriminate use of antimicrobials and the dissemination of antibiotic-resistant bacteria in the environment. The dynamics of human populations, including travel and worldwide distribution of food, contribute significantly to the rapid spread of resistant infectious micro-organisms (6). Moreover, the misuse of antibiotics in livestock is increasing the risk of spread of resistant micro-organisms to humans through food consumption (7). At the same time, the development of new antimicrobials is declining dramatically. |
| --- | --- |

(3)

The problem of drug resistance is a natural and unavoidable consequence of treating infectious diseases with antimicrobial drugs. However, this is exacerbated by indiscriminate use of antimicrobials and the dissemination of antibiotic-resistant bacteria in the environment. The dynamics of human populations, including travel and worldwide distribution of food, contribute significantly to the rapid spread of resistant infectious micro-organisms (6). Moreover, the misuse of antibiotics in livestock is increasing the risk of spread of resistant micro-organisms to humans through food consumption (7). At the same time, the development of new antimicrobials is declining dramatically.

| (4) | A comprehensive solution to the problem requires measures to be taken by many sectors of society: policy-makers, healthcare, education, industry, environmental agencies, agriculture, veterinary medicine, research and other areas. |
| --- | --- |

(4)

A comprehensive solution to the problem requires measures to be taken by many sectors of society: policy-makers, healthcare, education, industry, environmental agencies, agriculture, veterinary medicine, research and other areas.

| (5) | Cross-border collaboration is essential given that the increasing resistance of micro-organisms to antibiotics is not confined to individual countries, but poses a real threat to public health on a global scale. Sharing the burden in order to efficiently handle the challenges ahead will yield benefits for all countries involved and will enable better management and treatment of infectious diseases in the future. |
| --- | --- |

(5)

Cross-border collaboration is essential given that the increasing resistance of micro-organisms to antibiotics is not confined to individual countries, but poses a real threat to public health on a global scale. Sharing the burden in order to efficiently handle the challenges ahead will yield benefits for all countries involved and will enable better management and treatment of infectious diseases in the future.

| (6) | While excellent research is being carried out throughout Europe, the current European landscape for antimicrobial resistance research appears to be rather complex and fragmented. Many research networks and organisations at European and national level define antimicrobial resistance research agendas in isolation, leading to overlaps or competing research activities that often lack critical mass. |
| --- | --- |

(6)

While excellent research is being carried out throughout Europe, the current European landscape for antimicrobial resistance research appears to be rather complex and fragmented. Many research networks and organisations at European and national level define antimicrobial resistance research agendas in isolation, leading to overlaps or competing research activities that often lack critical mass.

| (7) | The Commission staff working paper of 18 November 2009 on antimicrobial resistance (8) summarised the initiatives in this field at Union level. Several actions were proposed and followed up, including the improved monitoring of antimicrobial resistance and usage, and also risk management measures. |
| --- | --- |

(7)

The Commission staff working paper of 18 November 2009 on antimicrobial resistance (8) summarised the initiatives in this field at Union level. Several actions were proposed and followed up, including the improved monitoring of antimicrobial resistance and usage, and also risk management measures.

| (8) | At its meeting of 1 December 2009 (9), the Council of the European Union called upon the Member States and the Commission to ‘support the sharing of research infrastructures, recruitment of researchers, stimulation of and support for global research cooperation, increasing the spread of research results and knowledge through information exchange structures and considering existing and new financial instruments’ on innovative incentives for effective antibiotics. |
| --- | --- |

(8)

At its meeting of 1 December 2009 (9), the Council of the European Union called upon the Member States and the Commission to ‘support the sharing of research infrastructures, recruitment of researchers, stimulation of and support for global research cooperation, increasing the spread of research results and knowledge through information exchange structures and considering existing and new financial instruments’ on innovative incentives for effective antibiotics.

| (9) | At its meeting of 26 May 2010 (10), the Competitiveness Council identified and substantiated a set of potential Joint Programming Initiatives (hereinafter referred to as JPIs), including ‘The Microbial Challenge — An Emerging Threat to Human Health’ as areas where joint research programming would provide major added value to the fragmented efforts currently being made by Member States. It therefore adopted conclusions recognising the need to launch a JPI on the subject and inviting the Commission to contribute to the preparation of that JPI. |
| --- | --- |

(9)

At its meeting of 26 May 2010 (10), the Competitiveness Council identified and substantiated a set of potential Joint Programming Initiatives (hereinafter referred to as JPIs), including ‘The Microbial Challenge — An Emerging Threat to Human Health’ as areas where joint research programming would provide major added value to the fragmented efforts currently being made by Member States. It therefore adopted conclusions recognising the need to launch a JPI on the subject and inviting the Commission to contribute to the preparation of that JPI.

| (10) | Member States have confirmed their participation in this JPI by the sending of formal letters of commitment. |
| --- | --- |

(10)

Member States have confirmed their participation in this JPI by the sending of formal letters of commitment.

| (11) | Joint programming in research in the area of antimicrobial resistance, as in the proposed initiative ‘The Microbial Challenge — An Emerging Threat to Human Health’, will contribute to tackling the fragmentation of research efforts by Member States and will step-up the mobilisation of skills, knowledge and resources, with a view to advancing and strengthening Europe’s leadership and research competitiveness in this field. In addition, by tackling a major societal challenge, it complements the Europe 2020 strategy (11) and the Innovation Union (12). |
| --- | --- |

(11)

Joint programming in research in the area of antimicrobial resistance, as in the proposed initiative ‘The Microbial Challenge — An Emerging Threat to Human Health’, will contribute to tackling the fragmentation of research efforts by Member States and will step-up the mobilisation of skills, knowledge and resources, with a view to advancing and strengthening Europe’s leadership and research competitiveness in this field. In addition, by tackling a major societal challenge, it complements the Europe 2020 strategy (11) and the Innovation Union (12).

| (12) | In order to achieve the goals set out in this Recommendation, Member States should ensure cooperation and synergy with major related initiatives such as: the Innovative Medicines Initiative; research, development and innovation supported by the Framework Programme, including in the fields of health, food, agriculture and environment, where necessary enabled by information technology, as well as other initiatives, such as relevant ERA-NETs. |
| --- | --- |

(12)

In order to achieve the goals set out in this Recommendation, Member States should ensure cooperation and synergy with major related initiatives such as: the Innovative Medicines Initiative; research, development and innovation supported by the Framework Programme, including in the fields of health, food, agriculture and environment, where necessary enabled by information technology, as well as other initiatives, such as relevant ERA-NETs.

| (13) | In order for the Commission to be able to report to the European Parliament and to the Council, Member States should report regularly to the Commission on the progress made on this JPI, |
| --- | --- |

(13)

In order for the Commission to be able to report to the European Parliament and to the Council, Member States should report regularly to the Commission on the progress made on this JPI,

HAS ADOPTED THIS RECOMMENDATION:

| 1. | Member States are encouraged to develop a common vision, based on a multidisciplinary approach, on how cooperation and coordination in the field of research at European level can improve, addressing the challenges of antimicrobial resistance and capitalising on the opportunities it presents, in order to ensure the efficiency of the joint efforts of the Member States. |
| --- | --- |

1.

Member States are encouraged to develop a common vision, based on a multidisciplinary approach, on how cooperation and coordination in the field of research at European level can improve, addressing the challenges of antimicrobial resistance and capitalising on the opportunities it presents, in order to ensure the efficiency of the joint efforts of the Member States.

| 2. | Member States are encouraged to develop a common Strategic Research Agenda (SRA) establishing medium to long-term research needs and objectives in the area of antimicrobial resistance. The SRA should be further developed towards an implementation plan, establishing priorities and timelines and specifying the actions, instruments and resources required for its implementation. |
| --- | --- |

2.

Member States are encouraged to develop a common Strategic Research Agenda (SRA) establishing medium to long-term research needs and objectives in the area of antimicrobial resistance. The SRA should be further developed towards an implementation plan, establishing priorities and timelines and specifying the actions, instruments and resources required for its implementation.

| 3. | Member States are encouraged to include the following actions, as part of the SRA and of the implementation plan:






  (a) | identifying and exchanging information on relevant national programmes and research activities; |
| --- | --- | --- |

3.

Member States are encouraged to include the following actions, as part of the SRA and of the implementation plan:

(a)

identifying and exchanging information on relevant national programmes and research activities;

| (b) | strengthening joint foresight exercises and technology assessment capacities; |
| --- | --- |

(b)

strengthening joint foresight exercises and technology assessment capacities;

| (c) | exchanging information, resources, best practices, methodologies and guidelines; |
| --- | --- |

(c)

exchanging information, resources, best practices, methodologies and guidelines;

| (d) | identifying areas or research activities that would benefit from coordination or joint calls for proposals or pooling of resources; |
| --- | --- |

(d)

identifying areas or research activities that would benefit from coordination or joint calls for proposals or pooling of resources;

| (e) | defining the detailed procedures for research to be undertaken jointly in the areas referred to in point (d); |
| --- | --- |

(e)

defining the detailed procedures for research to be undertaken jointly in the areas referred to in point (d);

| (f) | considering the needs for patient treatment and of healthcare systems when defining the objectives for research programmes on antimicrobial resistance; |
| --- | --- |

(f)

considering the needs for patient treatment and of healthcare systems when defining the objectives for research programmes on antimicrobial resistance;

| (g) | sharing, where appropriate, existing research infrastructures or developing new facilities, such as coordinated databanks or the development of models for studying antimicrobial resistance processes; |
| --- | --- |

(g)

sharing, where appropriate, existing research infrastructures or developing new facilities, such as coordinated databanks or the development of models for studying antimicrobial resistance processes;

| (h) | encouraging better collaboration between public and private sectors, as well as open innovation between different research activities and business sectors related to antimicrobial resistance; |
| --- | --- |

(h)

encouraging better collaboration between public and private sectors, as well as open innovation between different research activities and business sectors related to antimicrobial resistance;

| (i) | exporting and disseminating knowledge, innovation and interdisciplinary methodological approaches, as well as identifying and addressing obstacles in the research and innovation system that prevent innovative solutions with a societal benefit from getting to the market quicker; |
| --- | --- |

(i)

exporting and disseminating knowledge, innovation and interdisciplinary methodological approaches, as well as identifying and addressing obstacles in the research and innovation system that prevent innovative solutions with a societal benefit from getting to the market quicker;

| (j) | creating networks between centres dedicated to antimicrobial resistance research. |
| --- | --- |

(j)

creating networks between centres dedicated to antimicrobial resistance research.

| 4. | Member States are encouraged to maintain an efficient common management structure in the field of research on antimicrobial resistance, with a mandate to establish appropriate conditions, rules and procedures for cooperation and coordination, and to monitor the implementation of the SRA. This management structure should be lean, efficient and flexible, and should take account of the Voluntary Guidelines on Framework Conditions for Joint Programming in Research developed by the High Level Group on Joint Programming (GPC). |
| --- | --- |

4.

Member States are encouraged to maintain an efficient common management structure in the field of research on antimicrobial resistance, with a mandate to establish appropriate conditions, rules and procedures for cooperation and coordination, and to monitor the implementation of the SRA. This management structure should be lean, efficient and flexible, and should take account of the Voluntary Guidelines on Framework Conditions for Joint Programming in Research developed by the High Level Group on Joint Programming (GPC).

| 5. | Member States are encouraged to jointly implement the common SRA, including via their national research programmes in accordance with the Voluntary Guidelines on Framework Conditions for Joint Programming in Research developed by the GPC or other national research activities. |
| --- | --- |

5.

Member States are encouraged to jointly implement the common SRA, including via their national research programmes in accordance with the Voluntary Guidelines on Framework Conditions for Joint Programming in Research developed by the GPC or other national research activities.

| 6. | Member States are encouraged to build on the existing expertise within the Commission and take the Voluntary Guidelines on Framework Conditions into account when developing and implementing the SRA, and with a view to coordinating the JPIs with other programmes and initiatives in this field. |
| --- | --- |

6.

Member States are encouraged to build on the existing expertise within the Commission and take the Voluntary Guidelines on Framework Conditions into account when developing and implementing the SRA, and with a view to coordinating the JPIs with other programmes and initiatives in this field.

| 7. | Member States are encouraged to report regularly to the Council and to the Commission on the progress and results of this JPI, including lessons learned on achieving optimal efficiency. |
| --- | --- |

7.

Member States are encouraged to report regularly to the Council and to the Commission on the progress and results of this JPI, including lessons learned on achieving optimal efficiency.

Done at Brussels, 27 October 2011.

For the Commission

Máire GEOGHEGAN-QUINN

Member of the Commission

---

(1)  Priority Medicines for Europe and the World, Kaplan W, Laing R. Geneva: World Health Organization (2004).

1

(2)  The bacterial challenge: time to react. ECDC/EMA joint technical report (September 2009).

2

(3)  Goldstein FW. Penicillin-resistant Streptococcus pneumoniae: selection by both beta lactam and non-beta lactam antibiotics. J Antimicrob Chemother 44:141-144 (1999).

3

Streptococcus pneumoniae

(4)  See footnote 2.

4

(5)  Conference report; Innovative Incentives for Effective Antibacterials (2009).

5

(6)  World health report 2007. A safer future: global public health security in the 21st century. WHO (2007).

6

(7)  Joint opinion on antimicrobial resistance (AMR) focused on zoonotic infections. EFSA Journal 7(11):1372 (2009).

7

(8)  SANCO/6867/2009r6.

8

(9)  Council of the European Union. Council Conclusions on innovative incentives for effective antibiotics. Adopted at 2980th Employment, Social Policy, Health and Consumer Affairs Council Meeting in Brussels, 1 December 2009.

9

(10)  10246/10.

10

(11)  COM(2010) 2020.

11

(12)  COM(2010) 546.

12

---

II Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

| 28.10.2011 | EN | Official Journal of the European Union | C 315/4 |
| --- | --- | --- | --- |

28.10.2011

EN

Official Journal of the European Union

C 315/4

---

Non-opposition to a notified concentration

(Case COMP/M.6223 — Aegon/Banca Civica/Cajaburgos Vida)

(Text with EEA relevance)

2011/C 315/02

On 20 October 2011, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32011M6223. EUR-Lex is the on-line access to the European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32011M6223. EUR-Lex is the on-line access to the European law.

---

| 28.10.2011 | EN | Official Journal of the European Union | C 315/5 |
| --- | --- | --- | --- |

28.10.2011

EN

Official Journal of the European Union

C 315/5

---

Authorisation for State aid pursuant to Articles 107 and 108 of the TFEU

Cases where the Commission raises no objections

(Text with EEA relevance, except for products falling under Annex I to the Treaty)

2011/C 315/03

| Date of adoption of the decision | 20.9.2011 |
| --- | --- |
| Reference number of State Aid | SA.32899 (11/N) |
| Member State | Czech Republic |
| Region | — |
| Title (and/or name of the beneficiary) | Podpora vybraných činností zaměřených na ozdravování chovů prasat |
| Legal basis | — | Zákon č. 252/1997 Sb., o zemědělství |

Date of adoption of the decision

20.9.2011

Reference number of State Aid

SA.32899 (11/N)

Member State

Czech Republic

Region

—

Title (and/or name of the beneficiary)

Podpora vybraných činností zaměřených na ozdravování chovů prasat

Legal basis

—

Zákon č. 252/1997 Sb., o zemědělství

| — | Zákon č. 166/1999 Sb., o veterinární péči a o změnách některých souvisejících zákonů |
| --- | --- |

—

Zákon č. 166/1999 Sb., o veterinární péči a o změnách některých souvisejících zákonů

| — | Zásady, kterými se stanovují podmínky pro poskytování dotací na základě paragrafu 2 a paragrafu 2d zákona č. 252/1997 Sb., o zemědělství |
| --- | --- |

—

Zásady, kterými se stanovují podmínky pro poskytování dotací na základě paragrafu 2 a paragrafu 2d zákona č. 252/1997 Sb., o zemědělství

Type of measure

Scheme

—

Objective

Animal diseases

Form of aid

Direct grant

Budget

| | Overall budget: CZK 3 017 million |
| --- | --- |

Overall budget: CZK 3 017 million

| | Annual budget: CZK 431 million |
| --- | --- |

Annual budget: CZK 431 million

Intensity

100 %

Duration (period)

Until 31.12.2017

Economic sectors

Crop and animal production, hunting and related service activities

Name and address of the granting authority

| Ministerstvo zemědělství |
| --- |
| Těšnov 17 |
| 117 05 Praha 1 |
| ČESKÁ REPUBLIKA |

Ministerstvo zemědělství

Těšnov 17

117 05 Praha 1

ČESKÁ REPUBLIKA

Other information

—

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

http://ec.europa.eu/community_law/state_aids/state_aids_texts_en.htm

| Date of adoption of the decision | 20.9.2011 |
| --- | --- |
| Reference number of State Aid | SA.32900 (11/N) |
| Member State | Czech Republic |
| Region | — |
| Title (and/or name of the beneficiary) | Podpora vybraných činností zaměřených na ozdravování chovů drůbeže zvýšením biologické bezpečnosti |
| Legal basis | — | Zákon č. 252/1997 Sb., o zemědělství |

Date of adoption of the decision

20.9.2011

Reference number of State Aid

SA.32900 (11/N)

Member State

Czech Republic

Region

—

Title (and/or name of the beneficiary)

Podpora vybraných činností zaměřených na ozdravování chovů drůbeže zvýšením biologické bezpečnosti

Legal basis

—

Zákon č. 252/1997 Sb., o zemědělství

| — | Zákon č. 166/1999 Sb., o veterinární péči a o změnách některých souvisejících zákonů |
| --- | --- |

—

Zákon č. 166/1999 Sb., o veterinární péči a o změnách některých souvisejících zákonů

| — | Zásady, kterými se stanovují podmínky pro poskytování dotací na základě paragrafu 2 a paragrafu 2d zákona č. 252/1997 Sb., o zemědělství |
| --- | --- |

—

Zásady, kterými se stanovují podmínky pro poskytování dotací na základě paragrafu 2 a paragrafu 2d zákona č. 252/1997 Sb., o zemědělství

Type of measure

Scheme

—

Objective

Animal diseases

Form of aid

Direct grant

Budget

| | Overall budget: CZK 2 429 million |
| --- | --- |

Overall budget: CZK 2 429 million

| | Annual budget: CZK 347 million |
| --- | --- |

Annual budget: CZK 347 million

Intensity

100 %

Duration (period)

Until 31.12.2017

Economic sectors

Crop and animal production, hunting and related service activities

Name and address of the granting authority

| Ministerstvo zemědělství |
| --- |
| Těšnov 17 |
| 117 05 Praha 1 |
| ČESKÁ REPUBLIKA |

Ministerstvo zemědělství

Těšnov 17

117 05 Praha 1

ČESKÁ REPUBLIKA

Other information

—

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

http://ec.europa.eu/community_law/state_aids/state_aids_texts_en.htm

| Date of adoption of the decision | 20.9.2011 |
| --- | --- |
| Reference number of State Aid | SA.32928 (11/N) |
| Member State | Germany |
| Region | Bayern | — |
| Title (and/or name of the beneficiary) | Richtlinie des Bayerischen Staatsministeriums für Ernährung, Landwirtschaft und Forsten zur Einzelbetrieblichen Investitionsförderung |
| Legal basis | — | Ziffer IV.A. „Beihilfen für Investitionen in landwirtschaftliche Betriebe“ sowie IV.B „Beihilfen für Investitionen zur Verarbeitung und Vermarktung landwirtschaftlicher Erzeugnisse“ der Rahmenregelung der Gemeinschaft für staatliche Beihilfen im Agrar- und Forstsektor 2007-2013 (2006/C 319/01). |

Date of adoption of the decision

20.9.2011

Reference number of State Aid

SA.32928 (11/N)

Member State

Germany

Region

Bayern

—

Title (and/or name of the beneficiary)

Richtlinie des Bayerischen Staatsministeriums für Ernährung, Landwirtschaft und Forsten zur Einzelbetrieblichen Investitionsförderung

Legal basis

—

Ziffer IV.A. „Beihilfen für Investitionen in landwirtschaftliche Betriebe“ sowie IV.B „Beihilfen für Investitionen zur Verarbeitung und Vermarktung landwirtschaftlicher Erzeugnisse“ der Rahmenregelung der Gemeinschaft für staatliche Beihilfen im Agrar- und Forstsektor 2007-2013 (2006/C 319/01).

| — | Richtlinienentwurf des Bayerischen Staatsministeriums für Landwirtschaft und Forsten zur Einzelbetrieblichen Investitionsförderung |
| --- | --- |

—

Richtlinienentwurf des Bayerischen Staatsministeriums für Landwirtschaft und Forsten zur Einzelbetrieblichen Investitionsförderung

Type of measure

Scheme

—

Objective

Investments in agricultural holdings

Form of aid

Direct grant

Budget

| | Overall budget: EUR 345 million |
| --- | --- |

Overall budget: EUR 345 million

| | Annual budget: EUR 72 million |
| --- | --- |

Annual budget: EUR 72 million

Intensity

20 %

Duration (period)

Until 31.12.2013

Economic sectors

Agriculture, forestry and fishing

Name and address of the granting authority

| Staatliche Führungsakademie für Ernährung, Landwirtschaft und Forsten |
| --- |
| Am Lurzenhof 3c |
| 84036 Landshut |
| DEUTSCHLAND |

Staatliche Führungsakademie für Ernährung, Landwirtschaft und Forsten

Am Lurzenhof 3c

84036 Landshut

DEUTSCHLAND

Other information

—

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

http://ec.europa.eu/community_law/state_aids/state_aids_texts_en.htm

| Date of adoption of the decision | 22.9.2011 |
| --- | --- |
| Reference number of State Aid | SA.32939 (11/N) |
| Member State | Czech Republic |
| Region | — |
| Title (and/or name of the beneficiary) | Lesnická infrastruktura |
| Legal basis | 1) | Program rozvoje venkova České republiky na období 2007–2013 |

Date of adoption of the decision

22.9.2011

Reference number of State Aid

SA.32939 (11/N)

Member State

Czech Republic

Region

—

Title (and/or name of the beneficiary)

Lesnická infrastruktura

Legal basis

1)

Program rozvoje venkova České republiky na období 2007–2013

| 2) | Pravidla, kterými se stanovují podmínky pro poskytování dotace na projekty Programu rozvoje venkova ČR na období 2007–2013 (podopatření I.1.2.3 Lesnická infrastruktura) |
| --- | --- |

2)

Pravidla, kterými se stanovují podmínky pro poskytování dotace na projekty Programu rozvoje venkova ČR na období 2007–2013 (podopatření I.1.2.3 Lesnická infrastruktura)

Type of measure

Scheme

—

Objective

Forestry

Form of aid

Direct grant

Budget

Overall budget: CZK 500 million

Intensity

100 %

Duration (period)

Until 31.12.2013

Economic sectors

Forestry and logging

Name and address of the granting authority

| Ministerstvo zemědělství |
| --- |
| Těšnov 17 |
| 117 05 Praha 1 |
| ČESKÁ REPUBLIKA |

Ministerstvo zemědělství

Těšnov 17

117 05 Praha 1

ČESKÁ REPUBLIKA

Other information

—

The authentic text(s) of the decision, from which all confidential information has been removed, can be found at:

http://ec.europa.eu/community_law/state_aids/state_aids_texts_en.htm

---

IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

| 28.10.2011 | EN | Official Journal of the European Union | C 315/8 |
| --- | --- | --- | --- |

28.10.2011

EN

Official Journal of the European Union

C 315/8

---

Euro exchange rates (1)

27 October 2011

2011/C 315/04

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,4038 |
| JPY | Japanese yen | 106,39 |
| DKK | Danish krone | 7,4441 |
| GBP | Pound sterling | 0,87630 |
| SEK | Swedish krona | 9,0280 |
| CHF | Swiss franc | 1,2213 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 7,6560 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 24,833 |
| HUF | Hungarian forint | 302,20 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,7043 |
| PLN | Polish zloty | 4,3420 |
| RON | Romanian leu | 4,3323 |
| TRY | Turkish lira | 2,4798 |
| AUD | Australian dollar | 1,3188 |
| CAD | Canadian dollar | 1,3964 |
| HKD | Hong Kong dollar | 10,9113 |
| NZD | New Zealand dollar | 1,7231 |
| SGD | Singapore dollar | 1,7555 |
| KRW | South Korean won | 1 558,65 |
| ZAR | South African rand | 10,9256 |
| CNY | Chinese yuan renminbi | 8,9284 |
| HRK | Croatian kuna | 7,4900 |
| IDR | Indonesian rupiah | 12 381,61 |
| MYR | Malaysian ringgit | 4,3405 |
| PHP | Philippine peso | 60,146 |
| RUB | Russian rouble | 42,3128 |
| THB | Thai baht | 42,872 |
| BRL | Brazilian real | 2,4341 |
| MXN | Mexican peso | 18,5408 |
| INR | Indian rupee | 69,5020 |

Currency

Exchange rate

USD

US dollar

1,4038

JPY

Japanese yen

106,39

DKK

Danish krone

7,4441

GBP

Pound sterling

0,87630

SEK

Swedish krona

9,0280

CHF

Swiss franc

1,2213

ISK

Iceland króna

NOK

Norwegian krone

7,6560

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

24,833

HUF

Hungarian forint

302,20

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,7043

PLN

Polish zloty

4,3420

RON

Romanian leu

4,3323

TRY

Turkish lira

2,4798

AUD

Australian dollar

1,3188

CAD

Canadian dollar

1,3964

HKD

Hong Kong dollar

10,9113

NZD

New Zealand dollar

1,7231

SGD

Singapore dollar

1,7555

KRW

South Korean won

1 558,65

ZAR

South African rand

10,9256

CNY

Chinese yuan renminbi

8,9284

HRK

Croatian kuna

7,4900

IDR

Indonesian rupiah

12 381,61

MYR

Malaysian ringgit

4,3405

PHP

Philippine peso

60,146

RUB

Russian rouble

42,3128

THB

Thai baht

42,872

BRL

Brazilian real

2,4341

MXN

Mexican peso

18,5408

INR

Indian rupee

69,5020

---

(1)  Source: reference exchange rate published by the ECB.

---

NOTICES FROM MEMBER STATES

| 28.10.2011 | EN | Official Journal of the European Union | C 315/9 |
| --- | --- | --- | --- |

28.10.2011

EN

Official Journal of the European Union

C 315/9

---

Information communicated by Member States regarding State aid granted under Commission Regulation (EC) No 1857/2006 on the application of Articles 87 and 88 of the Treaty to State aid to small and medium-sized enterprises active in the production of agricultural products and amending Regulation (EC) No 70/2001

2011/C 315/05

Aid No: SA.33762 (11/XA)

Member State: Netherlands

Region: Nederland

Title of aid scheme or name of company receiving an individual aid: Steunmaatregelen technische ondersteuning en kwaliteitsbevordering bloemkwekerijproducten

Legal basis: Ontwerp-verordening PT heffing handel bloemkwekerijproducten 2010

Ontwerp-verordening PT heffing aanbod bloemkwekerijproducten 2010

Annual expenditure planned under the scheme or overall amount of individual aid granted to the company: Annual overall amount of the budget planned under the scheme: EUR 14,10 million

Maximum aid intensity: 100 %

Date of implementation: —

Duration of scheme or individual aid award: 26 October 2011-30 June 2014

Objective of aid: Production of quality agricultural products (Article 14 of Regulation (EC) No 1857/2006), Technical support (Article 15 of Regulation (EC) No 1857/2006)

Sector(s) concerned: Crop and animal production, hunting and related service activities

Name and address of the granting authority:

| Productschap Tuinbouw |
| --- |
| Postbus 280 |
| 2700 AG Zoetermeer |
| NEDERLAND |

Productschap Tuinbouw

Postbus 280

2700 AG Zoetermeer

NEDERLAND

| Louis Pasteurlaan 6 |
| --- |
| 2719 EE Zoetermeer |
| NEDERLAND |

Louis Pasteurlaan 6

2719 EE Zoetermeer

NEDERLAND

Website: http://www.tuinbouw.nl/files/page/Ontwerp-Verordening%20PT%20heffing%20handel%20bloemkwekerijproducten%202010.pdf

http://www.tuinbouw.nl/files/page/Ontwerp-Verordening%20PT%20heffing%20aanbod%20bloemkwekerijproducten%202010.pdf

Other information: —

Aid No: SA.33813 (11/XA)

Member State: France

Region: Moselle

Title of aid scheme or name of company receiving an individual aid: aides aux audits sanitaires des élevages et aux programmes pluriannuels d’intervention en Moselle.

Legal basis: Articles L 1511-2 et L 1511-5 du code général des collectivités territoriales,

délibération du Conseil général de la Moselle (Commission permanente du 13 décembre 2010).

Annual expenditure planned under the scheme or overall amount of individual aid granted to the company: Annual overall amount of the budget planned under the scheme: EUR 0,20 million

Maximum aid intensity: 100 %

Date of implementation: —

Duration of scheme or individual aid award: 26 October 2011-30 June 2014

Objective of aid: Animal diseases (Article 10 of Regulation (EC) No 1857/2006)

Sector(s) concerned: Animal production, Mixed farming

Name and address of the granting authority:

| Monsieur le Président du Conseil général de la Moselle |
| --- |
| Direction de l'environnement et de l'aménagement du territoire |
| Division de l'environnement et de l'espace rural/SAEN |
| Hôtel du Département |
| 1 rue du Pont Moreau |
| BP 11096 |
| 57036 Metz Cedex 1 |
| FRANCE |

Monsieur le Président du Conseil général de la Moselle

Direction de l'environnement et de l'aménagement du territoire

Division de l'environnement et de l'espace rural/SAEN

Hôtel du Département

1 rue du Pont Moreau

BP 11096

57036 Metz Cedex 1

FRANCE

Website: http://www.cg57.fr/SiteCollectionDocuments/LaMoselleEtVous/Agriculture/FichesUE/audit_sanitaire_et_programme_pluriannuel_elevages.pdf

Other information: —

Aid No: SA.33826 (11/XA)

Member State: Bulgaria

Region: Bulgaria

Title of aid scheme or name of company receiving an individual aid: Помощ за участие в изложение по овцевъдство-Специализирано регионално есенно изложение на Бели и Вакли Маришки овце с. Избегли общ. Асеновград обл. Пловдив

Legal basis: Чл. 12, ал. 1, т. 10 от Закона за подпомагане на земеделските производители; Указания, приети с Решение на Управителния съвет на Държавен фонд „Земеделие“ за схема на държавна помощ за участие в изложение

Annual expenditure planned under the scheme or overall amount of individual aid granted to the company: Annual overall amount of the budget planned under the scheme: BGN 0,02 million

Maximum aid intensity: 70 %

Date of implementation: —

Duration of scheme or individual aid award: 8 November 2011-31 December 2013

Objective of aid: Technical support (Article 15 of Regulation (EC) No 1857/2006)

Sector(s) concerned: Agriculture, forestry and fishing

Name and address of the granting authority:

| Държавен фонд „Земеделие“ |
| --- |
| бул. „Цар Борис III“ No 136 |
| 1618 София/Sofia |
| БЪЛГАРИЯ/ВULGАRIА |

Държавен фонд „Земеделие“

бул. „Цар Борис III“ No 136

1618 София/Sofia

БЪЛГАРИЯ/ВULGАRIА

Website: http://www.dfz.bg/bg/darzhavni-pomoshti/shemi_durjavni_pomoshti_reglament_1857_2006/

Other information: —

---

V Announcements

PROCEDURES RELATING TO THE IMPLEMENTATION OF COMPETITION POLICY

European Commission

| 28.10.2011 | EN | Official Journal of the European Union | C 315/11 |
| --- | --- | --- | --- |

28.10.2011

EN

Official Journal of the European Union

C 315/11

---

Prior notification of a concentration

(Case COMP/M.6404 — Hochtief Solutions/Ventizz/JV)

Candidate case for simplified procedure

(Text with EEA relevance)

2011/C 315/06

| 1. | On 21 October 2011, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which Hochtief Solutions AG (‘Hochtief Solutions’, Germany) and Ventizz Capital Fund IV L.P. (‘Ventizz IV’, Jersey) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of a newly created company constituting a joint venture (‘JV’, Luxembourg) by way of a purchase of shares. |
| --- | --- |

1.

On 21 October 2011, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which Hochtief Solutions AG (‘Hochtief Solutions’, Germany) and Ventizz Capital Fund IV L.P. (‘Ventizz IV’, Jersey) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of a newly created company constituting a joint venture (‘JV’, Luxembourg) by way of a purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | for Hochtief Solutions: active in a number of different business areas, including service solutions, real estate solutions, energy and infrastructure solutions, international project solutions, classic solutions and engineering solutions. Hochtief Solutions is part of the Hochtief Aktiengesellschaft group of companies, which is controlled by Actividades de Construcción y Servicios, SA (Spain), |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for Hochtief Solutions: active in a number of different business areas, including service solutions, real estate solutions, energy and infrastructure solutions, international project solutions, classic solutions and engineering solutions. Hochtief Solutions is part of the Hochtief Aktiengesellschaft group of companies, which is controlled by Actividades de Construcción y Servicios, SA (Spain),

| — | for Ventizz IV: a private equity fund investing primarily in the German speaking regions in high tech companies and providing these companies with additional equity, |
| --- | --- |

—

for Ventizz IV: a private equity fund investing primarily in the German speaking regions in high tech companies and providing these companies with additional equity,

| — | for JV: active in the project development for offshore wind farms primarily in the North Sea and the Baltic Sea. |
| --- | --- |

—

for JV: active in the project development for offshore wind farms primarily in the North Sea and the Baltic Sea.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the EC Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the EC Merger Regulation (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6404 — Hochtief Solutions/Ventizz/JV, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6404 — Hochtief Solutions/Ventizz/JV, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

1049 Bruxelles/Brussel

BELGIQUE/BELGIË

---

(1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

(2)  OJ C 56, 5.3.2005, p. 32 (‘Notice on a simplified procedure’).

---